KHCM
TTOO

Kettle Hill Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Kettle Hill Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6
Closed -$224K – 45
2018
Q2 		$224K Buy
+6
New +$228K 0.09% 33

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kettle Hill Capital Management's TTOO Position: Q3 2018 in Review

Kettle Hill Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2018, closing a stake of 6 shares — an estimated $224K sold.

Kettle Hill Capital Management first reported a position in TTOO in Q2 2018 and held it in 1 quarter. The position peaked at $224K in Q2 2018. 85 funds tracked by Wall St. Rank hold TTOO as of Q3 2018.

  • Kettle Hill Capital Management reported no remaining T2 Biosystems, Inc position as of Q3 2018 after selling out during the quarter.
  • Kettle Hill Capital Management sold 6 T2 Biosystems, Inc shares in Q3 2018, an estimated $224K.
  • Kettle Hill Capital Management first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 1 quarter.
  • Kettle Hill Capital Management's T2 Biosystems, Inc position peaked at $224K in Q2 2018.
  • 85 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2018.

Based on Kettle Hill Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.